About EyeSense
EyeSense is a company based in Stockstadt Am Main (Germany) founded in 2006. It operates as a HealthTech, and Product-as-a-Service. EyeSense has raised $8.23 million across 3 funding rounds from investors including Qiagen, Life Sciences Partners and Lee’s PHARM. The company has 15 employees as of December 31, 2020. EyeSense offers products and services including FiberSense Sensor and EyeSense App. EyeSense operates in a competitive market with competitors including Dexcom, Livongo, One Drop, mySugr and Laborie Medical, among others.
- Headquarter Stockstadt Am Main, Germany
- Employees 15 as on 31 Dec, 2020
-
Sectors
TechnologyHealthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Eyesense Gmbh
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$8.23 M (USD)
in 3 rounds
-
Latest Funding Round
-
Investors
Qiagen
& 5 more
-
Employee Count
15
as on Dec 31, 2020
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of EyeSense
EyeSense offers a comprehensive portfolio of products and services, including FiberSense Sensor and EyeSense App. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Continuous glucose monitoring is enabled by optical sensor.
Real-time glucose data is provided to users' smartphones.
Funding Insights of EyeSense
EyeSense has successfully raised a total of $8.23M across 3 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 3
- Last Round Last Round
-
First Round
First Round
(09 Feb 2006)
- Investors Count 6
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Nov, 2014 | Amount | Series C - EyeSense | Valuation |
investors |
|
| Jan, 2011 | Amount | Series B - EyeSense | Valuation |
investors |
|
| Feb, 2006 | Amount | Series A - EyeSense | Valuation | BioMedPartners , Life Sciences Partners |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in EyeSense
EyeSense has secured backing from 6 investors, including institutional and venture fund investors. Prominent investors backing the company include Qiagen, Life Sciences Partners and Lee’s PHARM. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital investment firm
|
Founded Year | Domain | Location | |
|
Private equity investments in life sciences businesses are managed.
|
Founded Year | Domain | Location | |
|
Early to mid stage life sciences-focused VC firm investing in geographies such as Europe
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by EyeSense
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - EyeSense
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Eyesense Comparisons
Competitors of EyeSense
EyeSense operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Dexcom, Livongo, One Drop, mySugr and Laborie Medical, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Wearable glucose monitoring patches are provided for real-time data tracking.
|
|
| domain | founded_year | HQ Location |
Provider of smart devices for diabetes management for patients and doctors
|
|
| domain | founded_year | HQ Location |
Provider of workforce healthcare solutions
|
|
| domain | founded_year | HQ Location |
Gamified apps for diabetes management and therapy are provided.
|
|
| domain | founded_year | HQ Location |
Medical products for female lower urinary tract dysfunctions are provided.
|
|
| domain | founded_year | HQ Location |
Implantable continuous glucose monitoring systems are provided for diabetes management.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Eyesense
Frequently Asked Questions about EyeSense
When was EyeSense founded?
EyeSense was founded in 2006.
Where is EyeSense located?
EyeSense is headquartered in Stockstadt Am Main, Germany. It is registered at Stockstadt Am Main, Bavaria, Germany.
Is EyeSense a funded company?
EyeSense is a funded company, having raised a total of $8.23M across 3 funding rounds to date. The company's 1st funding round was a Series A of $8.23M, raised on Feb 09, 2006.
How many employees does EyeSense have?
As of Dec 31, 2020, the latest employee count at EyeSense is 15.
What does EyeSense do?
Advanced medical technology for diabetes management is provided by EyeSense. Focus is placed on continuous glucose monitoring through innovative optical sensors. The FiberSense platform is designed for precision and sustainability, targeting Type-1 and Type-2 diabetes patients. Additional biometric data monitoring, such as ketones and cortisol, is planned for future expansion. The healthcare sector is served with solutions emphasizing reliability, discretion, and environmental responsibility. User-friendly systems with real-time alerts are integrated for seamless health management. Software updates are intended to ensure adaptability to evolving user needs.
Who are the top competitors of EyeSense?
EyeSense's top competitors include Dexcom, Senseonics and One Drop.
What products or services does EyeSense offer?
EyeSense offers FiberSense Sensor and EyeSense App.
Who are EyeSense's investors?
EyeSense has 6 investors. Key investors include Qiagen, Life Sciences Partners, Lee’s PHARM, Rosetta Capital, and BioMedPartners.